Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 12—December 2024
Research

Cost-effectiveness Analysis of Japanese Encephalitis Vaccination for Children <15 Years of Age, Bangladesh

An Nguyen1, Rebeca Sultana1Comments to Author , Elisabeth Vodicka, Zareen Tasnim, Kamran Mehedi, Md. Monjurul Islam, S.M. Abdullah Al Murad, Md. Redowan Ullah, Sharmin Sultana, Tahmina Shirin, and Clint Pecenka
Author affiliation: Program for Appropriate Technology in Health (PATH), Ho Chi Minh City, Vietnam (A. Nguyen); icddr,b, Dhaka, Bangladesh (R. Sultana, Z. Tasnim, M.R. Ullah); PATH, Seattle, Washington, USA (E. Vodicka, C. Pecenka); PATH, Dhaka (K. Mehedi); Maternal, Newborn, Child and Adolescent Health, Dhaka (M.M. Islam, S.M.A. Al Murad); Institute of Epidemiology Diseases Control and Research, Dhaka (S. Sultana, T. Shirin)

Main Article

Figure 2

Societal perspective for 1-way sensitivity analysis of key cost drivers for cost per DALY averted with strategy 1 in cost-effectiveness analysis of JE vaccination for children <15 years of age, Bangladesh. Strategy 1 consisted of a subnational 1-time immunization campaign for children <15 years of age and subnational routine immunization for 9-month-old children over 20 birth cohorts. The subnational approach focuses on 3 divisions with a high number of JE cases: Rangpur, Rajshahi, and Chattogram. Values are US dollars. JE, Japanese encephalitis virus.

Figure 2. Societal perspective for 1-way sensitivity analysis of key cost drivers for cost per DALY averted with strategy 1 in cost-effectiveness analysis of JE vaccination for children <15 years of age, Bangladesh. Strategy 1 consisted of a subnational 1-time immunization campaign for children <15 years of age and subnational routine immunization for 9-month-old children over 20 birth cohorts. The subnational approach focuses on 3 divisions with a high number of JE cases: Rangpur, Rajshahi, and Chattogram. Values are US dollars. JE, Japanese encephalitis virus.

Main Article

1These first authors contributed equally to this article.

Page created: August 29, 2024
Page updated: November 26, 2024
Page reviewed: November 26, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external